SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-20-002184
Filing Date
2020-07-06
Accepted
2020-07-02 20:36:08
Documents
4
Period of Report
2020-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K canna_8k.htm 8-K 21063
2 PURCHASE AGREEMENT WITH BRISTOL CAPITAL INVESTORS LLC canna_ex1005.htm EX-10.5 252992
3 PRESS RELEASE canna_ex9901.htm EX-99.1 7906
4 GRAPHIC image_005.jpg GRAPHIC 1216
  Complete submission text file 0001683168-20-002184.txt   285237
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27055 | Film No.: 201011838
SIC: 2834 Pharmaceutical Preparations